High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions-Reference-Cited by-同舟云学术

High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions

Published:2021-10 Issue:10 Volume:26 Page:2439-2444
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Xu Tuan^ORCID,Zheng Wei^ORCID,Huang Ruili^ORCID

Funder

Department of Primary Industries

National Institutes of Health

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference40 articles.

1. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China;Yang;J Autoimmun,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

3. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

4. Draft landscape and tracker of COVID-19 candidate vaccines. www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines [accessed May 18, 2021].

5. Prospects for a safe COVID-19 vaccine;Haynes;Sci Translat Med,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic;International Journal of Molecular Sciences;2023-12-26

2. Predicting anti-SARS-CoV-2 activities of chemical compounds using machine learning models;Artificial Intelligence Chemistry;2023-12

3. Mining for Bioactive Molecules in Open Databases;Methods and Principles in Medicinal Chemistry;2023-10-20

4. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication;Journal of Natural Products;2023-05-31

5. Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations;Circulation Research;2023-05-12